Barclays analyst Luke Sergott maintained a Buy rating on Bruker (BRKR – Research Report) today and set a price target of $60.00. The company’s ...

Stifel lowered the firm’s price target on Bruker (BRKR) to $57 from $70 and keeps a Hold rating on the shares. Bruker continues to show ...

Bruker expects full-year earnings in the range of $2.67 to $2.72 per share, with revenue in the range of $3.47 billion to $3.54 billion. Bruker shares have fallen 12% since the beginning of the year.

Bruker Corporation BRKR delivered adjusted earnings per share (EPS) of 76 cents for the fourth quarter of 2024, up 8.6% year ...

Scientific instrument company Bruker (NASDAQ:BRKR). reported Q4 CY2024 results , with sales up 14.6% year on year to $979.6 ...

Designed for the analysis of chemical processes by NMR, InsightMR is the ideal solution for both industrial and academic scientists studying or optimizing reactions. InsightMR’s two components ...

Bruker's minispec Whole Body Composition Analyzer based on TD-NMR provides a precise method for measurement of lean tissue, fat and fluid in living mice and rats. This body composition analyzer ...

After hours: February 13 at 5:04:50 PM EST Loading Chart for BRKR ...

Spatial Proteomics Market Spatial Proteomics Market Dublin, Feb. 11, 2025 (GLOBE NEWSWIRE) -- The "Spatial Proteomics Market ...

Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.